COVID-19(6) oncology(5) pandemic(5) risk(4) limit(4) global pandemic(4) required(4) Japan(4) South Korea(4) Enrollment(4) trial termination(4) Coronavirus disease 2019(4) FIVE(4) Drug development(4) Asia(4) analyzed(4) Determining(4) Hong Kong(4) Patients with cancer(4) situation(4) Treatment(4) deviation(4) protocol(4) novel coronavirus disease(4) initial(4) outcomes(4) dependent on(4) public health emergency(4) Guidance(4) Perspective(4)